Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$209.01 - $232.56 $6.27 Million - $6.97 Million
-29,989 Reduced 72.05%
11,634 $2.54 Million
Q4 2023

Feb 08, 2024

BUY
$197.69 - $227.29 $6.29 Million - $7.23 Million
31,817 Added 324.46%
41,623 $9.46 Million
Q3 2023

Oct 27, 2023

BUY
$201.05 - $221.7 $1.44 Million - $1.59 Million
7,166 Added 271.44%
9,806 $1.97 Million
Q2 2023

Aug 07, 2023

SELL
$211.93 - $241.33 $3.69 Million - $4.2 Million
-17,399 Reduced 86.83%
2,640 $637,000
Q1 2023

May 09, 2023

BUY
$213.32 - $257.83 $1.06 Million - $1.28 Million
4,975 Added 33.03%
20,039 $4.6 Million
Q4 2022

Feb 10, 2023

BUY
$203.72 - $248.97 $3.07 Million - $3.75 Million
15,064 New
15,064 $3.55 Million
Q2 2022

Aug 08, 2022

BUY
$213.86 - $277.87 $571,647 - $742,746
2,673 Added 18.1%
17,444 $4.09 Million
Q1 2022

May 13, 2022

BUY
$259.82 - $298.18 $592,389 - $679,850
2,280 Added 18.25%
14,771 $3.9 Million
Q4 2021

Feb 11, 2022

BUY
$271.6 - $314.21 $1.19 Million - $1.37 Million
4,373 Added 53.87%
12,491 $3.93 Million
Q3 2021

Nov 02, 2021

BUY
$274.82 - $308.34 $27,207 - $30,525
99 Added 1.23%
8,118 $2.29 Million
Q2 2021

Aug 13, 2021

BUY
$251.87 - $278.14 $392,161 - $433,063
1,557 Added 24.09%
8,019 $2.21 Million
Q1 2021

May 12, 2021

BUY
$204.88 - $255.03 $409 - $510
2 Added 0.03%
6,462 $1.65 Million
Q4 2020

Feb 11, 2021

BUY
$186.91 - $214.42 $804,460 - $922,863
4,304 Added 199.63%
6,460 $1.32 Million
Q3 2020

Nov 12, 2020

BUY
$167.03 - $201.3 $360,116 - $434,002
2,156 New
2,156 $406,000
Q2 2020

Aug 13, 2020

SELL
$113.31 - $182.44 $201,805 - $324,925
-1,781 Closed
0 $0
Q1 2020

May 06, 2020

SELL
$104.32 - $195.28 $508,977 - $952,771
-4,879 Reduced 73.26%
1,781 $225,000
Q4 2019

Feb 10, 2020

BUY
$163.48 - $173.61 $92,039 - $97,742
563 Added 9.23%
6,660 $1.13 Million
Q3 2019

Nov 08, 2019

SELL
$159.77 - $178.1 $357,085 - $398,053
-2,235 Reduced 26.82%
6,097 $1.02 Million
Q2 2019

Aug 12, 2019

SELL
$144.16 - $172.9 $7,640 - $9,163
-53 Reduced 0.63%
8,332 $1.44 Million
Q1 2019

May 13, 2019

SELL
$123.7 - $156.3 $1.13 Million - $1.43 Million
-9,149 Reduced 52.18%
8,385 $1.28 Million
Q4 2018

Feb 13, 2019

SELL
$120.82 - $174.09 $62,101 - $89,482
-514 Reduced 2.85%
17,534 $2.22 Million
Q3 2018

Nov 06, 2018

BUY
$167.67 - $188.27 $1.19 Million - $1.34 Million
7,095 Added 64.78%
18,048 $3.14 Million
Q2 2018

Aug 10, 2018

BUY
$160.33 - $189.41 $86,898 - $102,660
542 Added 5.21%
10,953 $1.97 Million
Q1 2018

May 07, 2018

BUY
$161.53 - $178.11 $1.68 Million - $1.85 Million
10,411 New
10,411 $1.68 Million
Q4 2017

Feb 06, 2018

SELL
$147.99 - $163.95 $1.64 Million - $1.81 Million
-11,049 Closed
0 $0
Q3 2017

Nov 08, 2017

BUY
$149.47 - $160.56 $1.65 Million - $1.77 Million
11,049
11,049 $1.67 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $22.1B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Ing Groep Nv Portfolio

Follow Ing Groep Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

News

Stay updated on Ing Groep Nv with notifications on news.